Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial

BACKGROUND Anaemia caused by iron deficiency is common in children younger than age 5 years in eastern Africa. However, there is concern that universal supplementation of children with iron and folic acid in areas of high malaria transmission might be harmful. METHODS We did a randomised, placebo-controlled trial, of children aged 1-35 months and living in Pemba, Zanzibar. We assigned children to daily oral supplementation with: iron (12.5 mg) and folic acid (50 mug; n=7950), iron, folic acid, and zinc (n=8120), or placebo (n=8006); children aged 1-11 months received half the dose. Our primary endpoints were all-cause mortality and admission to hospital. Analyses were by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN59549825. FINDINGS The iron and folic acid-containing groups of the trial were stopped early on Aug 19, 2003, on the recommendation of the data and safety monitoring board. To this date, 24 076 children contributed a follow-up of 25,524 child-years. Those who received iron and folic acid with or without zinc were 12% (95% CI 2-23, p=0.02) more likely to die or need treatment in hospital for an adverse event and 11% (1-23%, p=0.03) more likely to be admitted to hospital; there were also 15% (-7 to 41, p=0.19) more deaths in these groups. INTERPRETATION Routine supplementation with iron and folic acid in preschool children in a population with high rates of malaria can result in an increased risk of severe illness and death. In the presence of an active programme to detect and treat malaria and other infections, iron-deficient and anaemic children can benefit from supplementation. However, supplementation of those who are not iron deficient might be harmful. As such, current guidelines for universal supplementation with iron and folic acid should be revised.

[1]  E. Pollitt,et al.  Adverse effect of iron supplementation on weight gain of iron-replete young children , 1994, The Lancet.

[2]  A. Kuijsten,et al.  Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial , 2002, The Lancet.

[3]  K. Marsh,et al.  Iron deficiency and malaria among children living on the coast of Kenya. , 2004, The Journal of infectious diseases.

[4]  H. Powers,et al.  Effect of supplementary vitamins and iron on malaria indices in rural Gambian children. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[5]  Robert E Black,et al.  Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial , 2006, The Lancet.

[6]  J. van den Hombergh,et al.  Does iron therapy benefit children with severe malaria-associated anaemia? A clinical trial with 12 weeks supplementation of oral iron in young children from the Turiani Division, Tanzania. , 1996, Journal of tropical pediatrics.

[7]  P. Phillips-Howard,et al.  Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya. , 2003, The Journal of infectious diseases.

[8]  E. Weinberg.  The Role of Iron In Protozoan and Fungal Infectious Diseases , 1999, The Journal of eukaryotic microbiology.

[9]  C. J. Murray,et al.  The adverse effect of iron repletion on the course of certain infections. , 1978, British medical journal.

[10]  C. Rigamonti,et al.  Iron, hepatic stellate cells and fibrosis in chronic hepatitis C , 2002, European journal of clinical investigation.

[11]  S. Oppenheimer.  Iron and its relation to immunity and infectious disease. , 2001, The Journal of nutrition.

[12]  T. Theander,et al.  Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial , 2003, The Lancet.

[13]  C. Bogdan.  Nitric oxide and the regulation of gene expression. , 2001, Trends in cell biology.

[14]  L. Brunet.  Nitric oxide in parasitic infections. , 2001, International immunopharmacology.

[15]  Joanna E Cohen,et al.  Universities and tobacco money , 2001, BMJ : British Medical Journal.

[16]  S. Fairweather-Tait,et al.  Studies of iron:zinc interactions in adult rats and the effect of iron fortification of two commercial infant weaning products on iron and zinc status of weanling rats. , 1989, The Journal of nutrition.

[17]  D. Parry,et al.  Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. , 1992, The New England journal of medicine.

[18]  D Payne,et al.  Use and limitations of light microscopy for diagnosing malaria at the primary health care level. , 1988, Bulletin of the World Health Organization.

[19]  R. Hayes,et al.  The effects on malaria of treatment of iron-deficiency anaemia with oral iron in Gambian children. , 1989, Annals of tropical paediatrics.

[20]  B. Hoen.  Iron and infection: clinical experience. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  J. E. Hyde,et al.  Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy , 1999, Molecular microbiology.

[22]  P. Galan,et al.  Effect of daily iron supplementation on iron status, cell-mediated immunity, and incidence of infections in 6–36 month old Togolese children , 2000, European Journal of Clinical Nutrition.

[23]  R. Stoltzfus,et al.  Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia , 1998 .

[24]  E. Pollitt,et al.  Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study , 2001, BMJ : British Medical Journal.

[25]  C. Ani,et al.  A review of studies on the effect of iron deficiency on cognitive development in children. , 2001, The Journal of nutrition.

[26]  O. Hernell,et al.  Iron supplementation affects growth and morbidity of breast-fed infants: results of a randomized trial in Sweden and Honduras. , 2002, The Journal of nutrition.

[27]  A. Floreani,et al.  Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. , 1995, Journal of hepatology.

[28]  A. Romeo,et al.  Intracellular Chelation of Iron by Bipyridyl Inhibits DNA Virus Replication , 2001, The Journal of Biological Chemistry.

[29]  M. Tanner,et al.  Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants , 1997, The Lancet.

[30]  A. Tomkins.  Effect of iron supplementation on incidence of infectious illness in children: systematic review. , 2003, The Journal of pediatrics.

[31]  T M Therneau,et al.  rhDNase as an example of recurrent event analysis. , 1997, Statistics in medicine.

[32]  R. Stoltzfus,et al.  Low-dose daily iron supplementation for 12 months does not increase the prevalence of malarial infection or density of parasites in young Zanzibari children. , 2004, The Journal of nutrition.

[33]  S. Jaffar,et al.  Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[34]  B. V. van Oost,et al.  Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. , 1982, British medical journal.

[35]  M. Tanner,et al.  Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial , 2001, The Lancet.